Peptide Vaccine and Temozolomide for Metastatic Melanoma Patients
Clinical trial NCT01543464 · TERMINATED
Trial details
- NCT number
- NCT01543464
- Sponsor
- Inge Marie Svane
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2016-09-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.